CRA was retained by the petitioner in an IPR proceeding at the Patent Trial and Appeal Board (PTAB) to determine whether there was evidence of commercial success for certain pre-operative skin sterilization products. CRA’s team also conducted analyses demonstrating that the commercial performance of the product did not change following the issuance of the challenged patent. The PTAB found all challenged claims unpatentable and credited the testimony provided by Dr. Sean Sheridan.
CRA consultants recognized among leading IP professionals in the 2025 IAM Strategy 300
Daniel McGavock, Robert Goldman, and Dr. Richard Razgaitis were recognized as leading IP strategists by Intellectual Asset Management (IAM) in the latest...